GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
eorganization related items; litigation related items; impairment of PPE and intangible assets; IPO-related incentive plans as well as other income and expense items that management deems exceptional and that are expected to accumulate within the year to be over 2 M USD threshold (2024: 1 M USD threshold). These include transformation, carve-out and build-up related project costs as well as post-acquisition related accounting impacts.
Core EPS is calculated as Core net income divided by the weighted average number of outstanding shares.
Leverage is defined as Total Net Indebtedness divided by Core EBITDA on a twelve-months rolling basis.
Single training contact points, one healthcare professional can be trained more than once.
Dividend-bearing shares are all shares issued except for treasury shares held by Galderma Group AG or its direct or indirect fully owned subsidiaries as of the record date. The dividend will be paid in CHF. The dist
=*=*=*=*=*=
当前为第48/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页